UNIVERSAL EXERCISE UNIT and REBOUND THERAPY ON GENU RECURVATUM Cerebral Palsy Childeren
NCT ID: NCT07008521
Last Updated: 2025-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-03-01
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cross-Training and Locomotor Abilities in Cerebral Palsy
NCT06750081
Universal Exercise Unit Versus Functional Electrical Stimulation On Genu Recurvatum In Diplegic Cerebral Palsy
NCT06332729
Role of Rebound Therapy in the Rehabilitation of Children With Spastic Cerebral Palsy
NCT04712708
Effect of Core Stability Excercises Program on Reaching in Children With Cerebral Palsy
NCT05316090
Effectiveness of Universal Exercise Unit Exercise on Upper Limb Strength Using Biodex Isokinetic
NCT07233031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Control group: Children in this group will receive a traditional physical therapy program.
Study group (A): Children in this group will receive a traditional physical therapy program in addition to universal exercise unit program.
Study group (B): Children in this group will receive the same traditional physical therapy program in addition to rebound therapy.
Evaluation will be carried out for each child individually before and after 3 months of treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Control group: Children in this group will receive a traditional physical therapy program.
Traditional physical therapy program
traditional physical therapy program for contrl group
study group A
Study group (A): Children in this group will receive a traditional physical therapy program in addition to universal exercise unit program.
Universal exercise unit
universal exercise unit (UEU) for study groip (A)
Study group B
Study group (B): Children in this group will receive the same traditional physical therapy program in addition to rebound therapy
Rebound Therapy
rebound therpay for study group (B)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Universal exercise unit
universal exercise unit (UEU) for study groip (A)
Rebound Therapy
rebound therpay for study group (B)
Traditional physical therapy program
traditional physical therapy program for contrl group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Their ages will be ranged from 5-7 years old.
* They will have mild spasticity (grade 1 and 1+) according to Modified Ashworth scale .
* They will be in level I and II according to gross motor function classification system (GMFCS) .
* They will be able to understand orders given to them.
Exclusion Criteria
1. Visual or hearing impairment.
2. Severe limb deformities as structural genurecurvatum.
3. Surgical interference in the lower limbs for the last 6 months.
4. Botulinum toxin injection of the spastic lower limb muscles during the last six months.
5 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merhan Megahid Hamouda Bakr
assistant lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nanees Essam Mohamed, PhD
Role: STUDY_DIRECTOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Physical Therapy
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012005355
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.